List of Tables
Table 1. Global VEGF-A Inhibitor Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global VEGF-A Inhibitor Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global VEGF-A Inhibitor Market Competitive Situation by Manufacturers in 2025
Table 4. Global VEGF-A Inhibitor Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global VEGF-A Inhibitor Sales Market Share by Manufacturers (2021–2026)
Table 6. Global VEGF-A Inhibitor Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global VEGF-A Inhibitor Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market VEGF-A Inhibitor Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of VEGF-A Inhibitor, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of VEGF-A Inhibitor, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of VEGF-A Inhibitor, Product Types and Applications
Table 12. Global Key Manufacturers of VEGF-A Inhibitor, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global VEGF-A Inhibitor Companies by Tier (Tier 1, Tier 2, Tier 3), based on VEGF-A Inhibitor Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global VEGF-A Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global VEGF-A Inhibitor Sales by Region (K Units), 2021–2026
Table 18. Global VEGF-A Inhibitor Sales Market Share by Region (2021–2026)
Table 19. Global VEGF-A Inhibitor Sales by Region (K Units), 2027–2032
Table 20. Global VEGF-A Inhibitor Sales Market Share by Region (2027–2032)
Table 21. Global VEGF-A Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 22. Global VEGF-A Inhibitor Revenue Market Share by Region (2021–2026)
Table 23. Global VEGF-A Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 24. Global VEGF-A Inhibitor Revenue Market Share by Region (2027–2032)
Table 25. North America VEGF-A Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America VEGF-A Inhibitor Sales by Country (K Units), 2021–2026
Table 27. North America VEGF-A Inhibitor Sales by Country (K Units), 2027–2032
Table 28. North America VEGF-A Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 29. North America VEGF-A Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 30. Europe VEGF-A Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe VEGF-A Inhibitor Sales by Country (K Units), 2021–2026
Table 32. Europe VEGF-A Inhibitor Sales by Country (K Units), 2027–2032
Table 33. Europe VEGF-A Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 34. Europe VEGF-A Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific VEGF-A Inhibitor Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific VEGF-A Inhibitor Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific VEGF-A Inhibitor Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific VEGF-A Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific VEGF-A Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America VEGF-A Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America VEGF-A Inhibitor Sales by Country (K Units), 2021–2026
Table 42. Latin America VEGF-A Inhibitor Sales by Country (K Units), 2027–2032
Table 43. Latin America VEGF-A Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America VEGF-A Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa VEGF-A Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa VEGF-A Inhibitor Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa VEGF-A Inhibitor Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa VEGF-A Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa VEGF-A Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 50. Global VEGF-A Inhibitor Sales (K Units) by Type (2021–2026)
Table 51. Global VEGF-A Inhibitor Sales (K Units) by Type (2027–2032)
Table 52. Global VEGF-A Inhibitor Sales Market Share by Type (2021–2026)
Table 53. Global VEGF-A Inhibitor Sales Market Share by Type (2027–2032)
Table 54. Global VEGF-A Inhibitor Revenue (US$ Million) by Type (2021–2026)
Table 55. Global VEGF-A Inhibitor Revenue (US$ Million) by Type (2027–2032)
Table 56. Global VEGF-A Inhibitor Revenue Market Share by Type (2021–2026)
Table 57. Global VEGF-A Inhibitor Revenue Market Share by Type (2027–2032)
Table 58. Global VEGF-A Inhibitor Price (US$/Unit) by Type (2021–2026)
Table 59. Global VEGF-A Inhibitor Price (US$/Unit) by Type (2027–2032)
Table 60. Global VEGF-A Inhibitor Sales (K Units) by Application (2021–2026)
Table 61. Global VEGF-A Inhibitor Sales (K Units) by Application (2027–2032)
Table 62. Global VEGF-A Inhibitor Sales Market Share by Application (2021–2026)
Table 63. Global VEGF-A Inhibitor Sales Market Share by Application (2027–2032)
Table 64. Global VEGF-A Inhibitor Revenue (US$ Million) by Application (2021–2026)
Table 65. Global VEGF-A Inhibitor Revenue (US$ Million) by Application (2027–2032)
Table 66. Global VEGF-A Inhibitor Revenue Market Share by Application (2021–2026)
Table 67. Global VEGF-A Inhibitor Revenue Market Share by Application (2027–2032)
Table 68. Global VEGF-A Inhibitor Price (US$/Unit) by Application (2021–2026)
Table 69. Global VEGF-A Inhibitor Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis VEGF-A Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis VEGF-A Inhibitor Product
Table 74. Novartis Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche VEGF-A Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Roche VEGF-A Inhibitor Product
Table 79. Roche Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer VEGF-A Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pfizer VEGF-A Inhibitor Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Chengdu Kanghong Biotechnologies Co., Ltd. Company Information
Table 86. Chengdu Kanghong Biotechnologies Co., Ltd. Description and Business Overview
Table 87. Chengdu Kanghong Biotechnologies Co., Ltd. VEGF-A Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Chengdu Kanghong Biotechnologies Co., Ltd. VEGF-A Inhibitor Product
Table 89. Chengdu Kanghong Biotechnologies Co., Ltd. Recent Developments/Updates
Table 90. Innovent Biologics Company Information
Table 91. Innovent Biologics Description and Business Overview
Table 92. Innovent Biologics VEGF-A Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Innovent Biologics VEGF-A Inhibitor Product
Table 94. Innovent Biologics Recent Developments/Updates
Table 95. Luye Pharma Company Information
Table 96. Luye Pharma Description and Business Overview
Table 97. Luye Pharma VEGF-A Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Luye Pharma VEGF-A Inhibitor Product
Table 99. Luye Pharma Recent Developments/Updates
Table 100. 3SBio Company Information
Table 101. 3SBio Description and Business Overview
Table 102. 3SBio VEGF-A Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. 3SBio VEGF-A Inhibitor Product
Table 104. 3SBio Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. VEGF-A Inhibitor Distributors List
Table 108. VEGF-A Inhibitor Customers List
Table 109. VEGF-A Inhibitor Market Trends
Table 110. VEGF-A Inhibitor Market Drivers
Table 111. VEGF-A Inhibitor Market Challenges
Table 112. VEGF-A Inhibitor Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of VEGF-A Inhibitor
Figure 2. Global VEGF-A Inhibitor Market Value by Type (US$ Million), 2021–2032
Figure 3. Global VEGF-A Inhibitor Market Share by Type: 2025 & 2032
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Small Molecule Compound Product Picture
Figure 6. Global VEGF-A Inhibitor Market Value by Application (US$ Million), 2021–2032
Figure 7. Global VEGF-A Inhibitor Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global VEGF-A Inhibitor Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global VEGF-A Inhibitor Market Size (US$ Million), 2021–2032
Figure 13. Global VEGF-A Inhibitor Sales (K Units), 2021–2032
Figure 14. Global VEGF-A Inhibitor Average Price (US$/Unit), 2021–2032
Figure 15. VEGF-A Inhibitor Report Years Considered
Figure 16. VEGF-A Inhibitor Sales Share by Manufacturers in 2025
Figure 17. Global VEGF-A Inhibitor Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global VEGF-A Inhibitor Players: Market Share by Revenue in VEGF-A Inhibitor in 2025
Figure 19. VEGF-A Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global VEGF-A Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America VEGF-A Inhibitor Sales Market Share by Country (2021–2032)
Figure 22. North America VEGF-A Inhibitor Revenue Market Share by Country (2021–2032)
Figure 23. United States VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe VEGF-A Inhibitor Sales Market Share by Country (2021–2032)
Figure 26. Europe VEGF-A Inhibitor Revenue Market Share by Country (2021–2032)
Figure 27. Germany VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific VEGF-A Inhibitor Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific VEGF-A Inhibitor Revenue Market Share by Region (2021–2032)
Figure 34. China VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America VEGF-A Inhibitor Sales Market Share by Country (2021–2032)
Figure 42. Latin America VEGF-A Inhibitor Revenue Market Share by Country (2021–2032)
Figure 43. Mexico VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa VEGF-A Inhibitor Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa VEGF-A Inhibitor Revenue Market Share by Country (2021–2032)
Figure 49. Turkey VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE VEGF-A Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of VEGF-A Inhibitor by Type (2021–2032)
Figure 53. Global Revenue Market Share of VEGF-A Inhibitor by Type (2021–2032)
Figure 54. Global VEGF-A Inhibitor Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of VEGF-A Inhibitor by Application (2021–2032)
Figure 56. Global Revenue Market Share of VEGF-A Inhibitor by Application (2021–2032)
Figure 57. Global VEGF-A Inhibitor Price (US$/Unit) by Application (2021–2032)
Figure 58. VEGF-A Inhibitor Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
